Global Transdermal Drug Delivery System Market: Analysis By Type (Patches, Gels), By Technique (Ionophoresis, Electroporation, Sonophoresis, Others), By End-User, By Region, By Country (2018 Edition): Trends, Opportunities And Forecast (2013-2023)

Table of Content

1. Research Methodology

2. Executive Summary

3. Strategic Recommendation
3.1 Increase bioavailability of poor penetration drugs and increase application of transdermal drug delivery system
3.2 APAC region to witness augmented growth in the forecast period

4. Transdermal Drug Delivery System Outlook

5. Transdermal Drug Delivery System Market: Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)

6. Transdermal Drug Delivery System Market: Segmental Analysis
6.1 Transdermal Drug Delivery System Market Size, By Type: Breakdown (%)
6.1.1 Transdermal Drug Delivery System Market Size, By Type, 2017 (%)
6.1.2 Transdermal Drug Delivery System Market Size, By Type, 2023 (%)
6.2 Global Patches Type Market Size, By Value (2013-2023)
6.3 Global Gels Type Market Size, By Value (2013-2023)
6.4 Global Transdermal Drug Delivery System Market Size, By Technique : Breakdown(%)
6.4.1 Transdermal Drug Delivery System Market Size, By Technique, 2017 (%)
6.4.2 Transdermal Drug Delivery System Market Size, By Technique, 2023 (%)
6.5 Global Iontophoresis Technique TDDS Market Size, By Value (2013-2023)
6.6 Global Electroporation Technique TDDS Market Size, By Value (2013-2023)
6.7 Global Sonophoresis Technique TDDS Market Size, By Value (2013-2023)
6.8 Global Others Technique TDDS Market Size, By Value (2013-2023)
6.9 Global Transdermal Drug Delivery System Market Size, By End User: Breakdown (%)
6.9.1 Transdermal Drug Delivery System System Market Size, By End User, 2017 (%)
6.9.2 Transdermal Drug Delivery System System Market Size, By End User , 2023 (%)
6.10 Global Hospital & Clinic Transdermal Drug Delivery System Market Size, By Value (2013-2023)
6.11 Global Homecare Transdermal Drug Delivery System Market Size, By Value (2013-2023)

7. Transdermal Drug Delivery System Market: Regional Analysis
7.1 Transdermal Drug Delivery System Market Size, By Region : Breakdown (%)
7.1.1 Transdermal Drug Delivery System Market Size, By Region, 2017 (%)
7.1.2 Transdermal Drug Delivery System Market Size, By Region, 2023 (%)

7.2 North America Transdermal Drug Delivery System Market: Growth and Forecast
7.2.1 By Value (2013-2017)
7.2.2 By Value (2018-2023)
7.2.3 By Type, By Value (2013-2017)
7.2.4 By Type, By Value (2018-2023)
7.2.5 By Technique, By Value (2013-2017)
7.2.6 By Technique, By Value (2018-2023)
7.2.7 By End User, By Value (2013-2017)
7.2.8 By End User, By Value (2018-2023)

7.3 North America Transdermal Drug Delivery System Market: Country Analysis (U.S and Canada)
7.3.1 U.S. Transdermal Drug Delivery System Market, By Value (2013-2023)
7.3.2 U.S. Transdermal Drug Delivery System Market, By Type, By Value (2013-2017)
7.3.3 U.S. Transdermal Drug Delivery System Market, By Type, By Value (2018-2023)
7.3.4 U.S. Transdermal Drug Delivery System Market, By Technique, By Value (2013-2017)
7.3.5 U.S. Transdermal Drug Delivery System Market, By Technique, By Value (2018-2023)
7.3.6 U.S. Transdermal Drug Delivery System Market, By End User, By Value (2013-2017)
7.3.7 U.S. Transdermal Drug Delivery System Market, By End User, By Value (2018-2023)

7.3.8 Canada Transdermal Drug Delivery System Market, By Value (2013-2023)
7.3.9 Canada Transdermal Drug Delivery System Market, By Type, By Value (2013-2017)
7.3.10 Canada Transdermal Drug Delivery System Market, By Type, By Value (2018-2023)
7.3.11 Canada Transdermal Drug Delivery System Market, By Technique, By Value (2013-2017)
7.3.12 Canada Transdermal Drug Delivery System Market, By Technique, By Value (2018-2023)
7.3.13 Canada Transdermal Drug Delivery System Market, By End User, By Value (2013-2017)
7.3.14 Canada Transdermal Drug Delivery System Market, By End User, By Value (2018-2023)

7.4 Europe Transdermal Drug Delivery System Market: Growth and Forecast
7.4.1 By Value (2013-2017)
7.4.2 By Value (2018-2023)
7.4.3 By Type, By Value (2013-2017)
7.4.4 By Type, By Value (2018-2023)
7.4.5 By Technique, By Value (2013-2017)
7.4.6 By Technique, By Value (2018-2023)
7.4.7 By End User, By Value (2013-2017)
7.4.8 By End User, By Value (2018-2023)

7.5 Europe Transdermal Drug Delivery System Market: Country Analysis (U.K and Germany)
7.5.1 U.K. Transdermal Drug Delivery System Market, By Value (2013-2023)
7.5.2 U.K. Transdermal Drug Delivery System Market, By Type, By Value (2013-2017)
7.5.3 U.K. Transdermal Drug Delivery System Market, By Type, By Value (2018-2023)
7.5.4 U.K. Transdermal Drug Delivery System Market, By Technique, By Value (2013-2017)
7.5.5 U.K. Transdermal Drug Delivery System Market, By Technique, By Value (2018-2023)
7.5.6 U.K. Transdermal Drug Delivery System Market, By End User, By Value (2013-2017)
7.5.7 U.K. Transdermal Drug Delivery System Market, By End User, By Value (2018-2023)

7.5.8 Germany Transdermal Drug Delivery System Market, By Value (2013-2023)
7.5.9 Germany Transdermal Drug Delivery System Market, By Type, By Value (2013-2017)
7.5.10 Germany Transdermal Drug Delivery System Market, By Type, By Value (2018-2023)
7.5.11 Germany Transdermal Drug Delivery System Market, By Technique, By Value (2013-2017)
7.5.12 Germany Transdermal Drug Delivery System Market, By Technique, By Value (2018-2023)
7.5.13 Germany Transdermal Drug Delivery System Market, By End User, By Value (2013-2017)
7.5.14 Germany Transdermal Drug Delivery System Market, By End User, By Value (2018-2023)

7.6 APAC Transdermal Drug Delivery System Market: Growth and Forecast
7.6.1 By Value (2013-2017)
7.6.2 By Value (2018-2023)
7.6.3 By Type, By Value (2013-2017)
7.6.4 By Type, By Value (2018-2023)
7.6.5 By Technique, By Value (2013-2017)
7.6.6 By Technique, By Value (2018-2023)
7.6.7 By End user, By Value (2013-2017)
7.6.8 By End user, By Value (2018-2023)

7.7 APAC Transdermal Drug Delivery System Market: Country Analysis (Japan, India and China)
7.7.1 Japan Transdermal Drug Delivery System Market, By Value (2013-2023)
7.7.2 Japan Transdermal Drug Delivery System Market, By Type, By Value (2013-2017)
7.7.3 Japan Transdermal Drug Delivery System Market, By Type, By Value (2018-2023)
7.7.4 Japan Transdermal Drug Delivery System Market, By Technique, By Value (2013-2017)
7.7.5 Japan Transdermal Drug Delivery System Market, By Technique, By Value (2018-2023)
7.7.4 Japan Transdermal Drug Delivery System Market, By End user, By Value (2013-2017)
7.7.5 Japan Transdermal Drug Delivery System Market, By End user, By Value (2018-2023)

7.7.6 India Transdermal Drug Delivery System Market, By Value (2013-2023)
7.7.7 India Transdermal Drug Delivery System Market, By Type, By Value (2013-2017)
7.7.8 India Transdermal Drug Delivery System Market, By Type, By Value (2018-2023)
7.7.9 India Transdermal Drug Delivery System Market, By Technique, By Value (2013-2017)
7.7.10 India Transdermal Drug Delivery System Market, By Technique, By Value (2018-2023)
7.7.11 India Transdermal Drug Delivery System Market, By End user,, By Value (2013-2017)
7.7.12 India Transdermal Drug Delivery System Market, By End user, By Value (2018-2023)

7.7.13 China Transdermal Drug Delivery System Market, By Value (2013-2023)
7.7.14 China Transdermal Drug Delivery System Market, By Type, By Value (2013-2017)
7.7.15 China Transdermal Drug Delivery System Market, By Type, By Value (2018-2023)
7.7.16 China Transdermal Drug Delivery System Market, By Technique, By Value (2013-2017)
7.7.17 China Transdermal Drug Delivery System Market, By Technique, By Value (2018-2023)
7.7.18 China Transdermal Drug Delivery System Market, By End User, By Value (2013-2017)
7.7.19 China Transdermal Drug Delivery System Market, By End User, By Value (2018-2023)

7.8 ROW Transdermal Drug Delivery System Market: Growth and Forecast
7.8.1 By Value (2013-2017)
7.8.2 By Value (2018-2023)
7.8.3 By Type, By Value (2013-2017)
7.8.4 By Type, By Value (2018-2023)
7.8.5 By Technique, By Value (2013-2017)
7.8.6 By Technique, By Value (2018-2023)
7.8.7 By End User, By Value (2013-2017)
7.8.8 By End User, By Value (2018-2023)

7.9 ROW Transdermal Drug Delivery System Market: Country Analysis (Brazil)
7.9.1 Brazil Transdermal Drug Delivery System Market, By Value (2013-2023)
7.9.2 Brazil Transdermal Drug Delivery System Market, By Type, By Value (2013-2017)
7.9.3 Brazil Transdermal Drug Delivery System Market, By Type, By Value (2018-2023)
7.9.4 Brazil Transdermal Drug Delivery System Market, By Technique, By Value (2013-2017)
7.9.5 Brazil Transdermal Drug Delivery System Market, By Technique, By Value (2018-2023)
7.9.6 Brazil Transdermal Drug Delivery System Market, By End User, By Value (2013-2017)
7.9.7 Brazil Transdermal Drug Delivery System Market, By End User, By Value (2018-2023)

8. Transdermal Drug Delivery System Market Dynamics
8.1 Transdermal Drug Delivery System Market Drivers
8.2 Transdermal Drug Delivery System Market Restraints
8.3 Transdermal Drug Delivery System Market Trends

9. Porter Five Force Analysis

10. SWOT Analysis

11. Supply Chain Analysis

12. Policy and Regulatory Landscape

13. Company Profiling
13.1 3 M Pharmaceutical
13.2 Boehringer Ingelheim
13.3 Mylan
13.4 Novartis
13.5 GlaxoSmithKline
13.6 Noven
13.7 Lohmann Therapeutics System
13.8 Johnson & Johnson
13.9 Bayer AG
13.10 Corium International

14. About Us

List of Figure

Figure 1: Key Facts on Global Health Risk Diseases
Figure 2: Global Transdermal Drug Delivery System System Market Size, By Value, 2013-2017 (USD Billion)
Figure 3: Global Transdermal Drug Delivery System System Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Figure 4: Prevalence of hypertension, By Region, 2018( In %)
Figure 5: Worldwide projection of Alzheimer prevalence 2005-2050 (In Million)
Figure 6: Distribution of Cardiovascular disease deaths, 2015 (In %)
Figure 7: Consequences of uncontrolled hypertension
Figure 8: Prevalence of Smoking, By Country, 2016 (In %)
Figure 9: Distribution of Abortions across Globe, 2015 (In %)
Figure 10: GDP Per Capita PPP, By Region, 2018 (in Thousand USD)
Figure 11: GDP Per Capita PPP, By Select Countries, 2022F (USD)
Figure 12: Healthcare Expenditure (Share of GDP), By Select Country, 2013-2017 (In %)
Figure 13: Transdermal Drug Delivery System System Market Size, By Type, 2017 (In %)
Figure 14: Transdermal Drug Delivery System System Market Size, By Type, 2023 (In %)
Figure 15: Global Patches Type Market, By Value, 2013-2017 (USD Billion)
Figure 16: Global Patches Type Market, By Value, Forecast, 2018-2023(USD Billion)
Figure 17: Global Gels Type Market, By Value, 2013-2017 (USD Billion)
Figure 18: Global Gels Type Market, By Value, Forecast, 2018-2023(USD Billion)
Figure 19: Transdermal Drug Delivery System Market Size, By Technique, 2017 (In %)
Figure 20: Transdermal Drug Delivery System System Market Size, By Technique, 2023 (In %)
Figure 21: Global Iontophoresis Technique TDDS Market, By Value, 2013-2017 (USD Billion)
Figure 22: Global Iontophoresis Technique TDDS Market, By Value, Forecast, 2018-2023(USD Billion)
Figure 23: Global Electroporation Technique Market, By Value, 2013-2017 (USD Billion)
Figure 24: Global Electroporation Technique Market, By Value, Forecast, 2018-2023(USD Billion)
Figure 25: Global Sonophoresis Technique Market, By Value, 2013-2017 (USD Billion)
Figure 26: Global Sonophoresis Technique Market, By Value, Forecast, 2018-2023(USD Billion)
Figure 27: Global Other Techniques Market, By Value, 2013-2017 (USD Billion)
Figure 28: Global Other Techniques Market, By Value, Forecast, 2018-2023(USD Billion)
Figure 29: Transdermal Drug Delivery System Market Size, By End User, 2017 (In %)
Figure 30: Transdermal Drug Delivery System Market Size, By End User, 2023 (In %)
Figure 31: Global Hospital & Clinic Transdermal Drug Delivery System Market, By Value, 2013-2017 (USD Billion)
Figure 32: Global Hospital & Clinic Transdermal Drug Delivery System Market, By Value, Forecast, 2018-2023(USD Billion)
Figure 33: Global Homecare Transdermal Drug Delivery System Market, By Value, 2013-2017 (USD Billion)
Figure 34: Global Homecare Transdermal Drug Delivery System Market, By Value, Forecast, 2018-2023 (USD Billion)
Figure 35: Global Healthcare Landscape, By Select Region
Figure 36: Transdermal Drug Delivery System Market Size, By Region, 2017 (In %)
Figure 37: Transdermal Drug Delivery System Market Size, By Region, 2023 (In %)
Figure 38: North America Transdermal Drug Delivery System Market Size, By Value, 2013-2017 (USD Billion)
Figure 39: North America Transdermal Drug Delivery System Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Figure 40: North America Healthcare Cost Per Capita, 2017 (USD)
Figure 41: North America Population Ages 65 and above, 2012-2017 (% of Total)
Figure 42: North America GDP, 2012-2017 (USD Trillion)
Figure 43: North America GDP per capita, current prices, 2013-2023F (In USD)
Figure 44: North America Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 45: North America Transdermal Drug Delivery System Market: By Type, By Value, 2018E-2023F (USD Billion)
Figure 46: North America Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion)
Figure 47: North America Transdermal Drug Delivery System Market: By Technique, By Value, 2018E-2023F (USD Billion)
Figure 48: North America Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)
Figure 49: North America Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)
Figure 50: U.S. Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion)
Figure 51: U.S. Per Capita Expenditure on Healthcare, 2012-2018E (In USD)
Figure 52: U.S. Population ages 65 and above, 2013-2017 (% of total)
Figure 53: U.S. Population ages 65 and above, Forecast (In Billions)
Figure 54: U.S. Diseases developed by smoking addicts (in number)
Figure 55: U.S. GDP (Current USD), 2013-2017 (In USD Trillion)
Figure 56: U.S. Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 57: U.S. Transdermal Drug Delivery System Market: By Type, By Value, 2018-2023 (USD Billion)
Figure 58: U.S. Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion)
Figure 59: U.S. Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion)
Figure 60: U.S. Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)
Figure 61: U.S. Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)
Figure 62: Canada Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion)
Figure 63: Canada Expenditure on Health as a share of GDP, 2012-2017 (in %)
Figure 64: Canada Per Capita Healthcare Expenditure, 2012-2017 (USD)
Figure 65: Canada Population ages 65 and above, 2012-2017 (% of total)
Figure 66: Canada Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 67: Canada Transdermal Drug Delivery System Market: By Type, By Value, 2018-2023 (USD Billion)
Figure 68: Canada Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion)
Figure 69: Canada Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion)
Figure 70: Canada Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)
Figure 71: Canada Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)
Figure 72: North America Transdermal Drug Delivery System Market, Country Share, 2013-2017E (% of Total)
Figure 73: North America Transdermal Drug Delivery System Market, Country Share, 2018F-2023F (% of Total)
Figure 74: Europe Transdermal Drug Delivery System Market Size, By Value, 2013-2017 (USD Billion)
Figure 75: Europe Transdermal Drug Delivery System Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Figure 76: Per Capita Health Expenditure, By Select Country, 2017 (USD)
Figure 77: European Union, Population ages 65 and above, 2013-2017 (% of total)
Figure 78: European Country Population Aged 65 and Above, 2012-2017 (% of Total)
Figure 79: GDP, Europe Region, By Select Country, 2017 (In Trillion USD)
Figure 80: Europe Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 81: Europe Transdermal Drug Delivery System Market: By Product, By Value, 2018E-2023F (USD Billion)
Figure 82: Europe Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion)
Figure 83: Europe Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion)
Figure 84: Europe Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)
Figure 85: Europe Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)
Figure 86: U.K. Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion)
Figure 87: U.K. Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Figure 88: U.K. Population Ages 65 and Above (% of total), 2012-2017
Figure 89: U.K. Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 90: U.K. Transdermal Drug Delivery System Market: By Type, By Value, 2018-2023 (USD Billion)
Figure 91: U.K. Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion)
Figure 92: U.K. Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion)
Figure 93: U.K. Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)
Figure 94: U.K. Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)
Figure 95: Germany Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion)
Figure 96: Germany Age Structure Breakdown, 2017 (In %)
Figure 97: Germany Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Figure 98: Germany Population ages 65 and above, 2012-2017 (% total)
Figure 99: Germany Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 100: Germany Transdermal drug Delivery System Market: By Type, By Value, 2018-2023 (USD Billion)
Figure 101: Germany Transdermal Drug Delivery System Market: By Technique, By Value, 2013-2017 (USD Billion)
Figure 102: Germany Transdermal Drug Delivery System Market: By Technique, By Value, 2018-2023 (USD Billion)
Figure 103: Germany Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)
Figure 104: Germany Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)
Figure 105: Europe Transdermal Drug Delivery System Market, Country Share, Historic, 2013-2017(% of Total)
Figure 106: Europe Transdermal Drug Delivery System Market, Country Share, Forecast, 2018-2023 (% of Total)
Figure 107: APAC Transdermal Drug Delivery System Market Size, By Value, 2013-2017 (USD Billion)
Figure 108: APAC Transdermal Drug Delivery System Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Figure 109: APAC GDP By Select Country, 2017 (In USD Trillion)
Figure 110: Population ages 65 and above, APAC Region, By Select Countries, 2017 (% of total)
Figure 111: Population ages 65 and above, APAC Region, By Select Countries, 2050 (% of total)
Figure 112: APAC Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 113: APAC Transdermal Drug Delivery System Market: By Type, By Value, 2018E-2023F (USD Billion)
Figure 114: APAC Transdermal Drug Delivery System Market: By Technique , By Value, 2013-2017 (USD Billion)
Figure 115: APAC Transdermal Drug Delivery System Market: By Technique , By Value, 2018-2023 (USD Billion)
Figure 116: APAC Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)
Figure 117: APAC Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)
Figure 118: Japan Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion)
Figure 119: Japan GDP Growth Per Year, 2015-2019F (In %)
Figure 120: Japan Healthcare Expenditure Outlook (2016) (%)
Figure 121: Japan Population ages 65 and above, 2012-2016 (% of total)
Figure 122: Japan Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 123: Japan Transdermal Drug Delivery System Market: By Type, By Value, 2018E-2023F (USD Billion)
Figure 124: Japan Transdermal Drug Delivery System Market: By Technique, By Value, 2013-2017 (USD Billion)
Figure 125: Japan Transdermal Drug Delivery System Market: By Technique, By Value, 2018-2023 (USD Billion)
Figure 126: Japan Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)
Figure 127: Japan Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)
Figure 128: India Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion)
Figure 129: India Population ages 65 and above, 2012-2017
Figure 130: India Share of Urban Population, 2012-2017 (In %)
Figure 131: India GDP Growth Per Year, 2015-2019 (In %)
Figure 132: India Total Population, 2013-2023F (In Billion)
Figure 133: India Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 134: India Transdermal Drug Delivery System Market: By Type, By Value, 2018E-2023F (USD Billion)
Figure 135: India Transdermal Drug Delivery System Market: By Technique, By Value, 2013-2017 (USD Billion)
Figure 136: India Transdermal Drug Delivery System Market: By Technique, By Value, 2018-2023 (USD Billion)
Figure 137: India Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)
Figure 138: India Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)
Figure 139: China Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion)
Figure 140: China Population aged 65 and above, 2012-2017 (% of total)
Figure 141: China Healthcare Expenditure Outlook (2017) (%)
Figure 142: China GDP Growth Per Year, 2015-2019 (In %)
Figure 143: China Share of Urban Population, 2012-2017 (In %)
Figure 144: China Total Population, 2013-2021F (In Billion)
Figure 145: China Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 146: China Transdermal Drug Delivery System Market: By Type, By Value, 2018E-2023F (USD Billion
Figure 147: China Transdermal Drug Delivery System Market: By Technique, By Value, 2013-2017 (USD Billion)
Figure 148: China Transdermal Drug Delivery System Market: By Technique, By Value, 2018-2023 (USD Billion)
Figure 149: China Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)
Figure 150: China Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)
Figure 151: APAC Transdermal Drug Delivery System Market, Country Share, 2013-2017 (% of Total)
Figure 152: APAC Transdermal Drug Delivery System Market, Country Share, 2018-2023 (% of Total)
Figure 153: ROW Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion)
Figure 154: Latin America and Caribbean, Population ages 65 and above (% of total)
Figure 155: Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2017 (In %)
Figure 156: Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2017 (In %)
Figure 157: Middle East and North Africa, GDP, 2012-2017 (In USD Trillion)
Figure 158: ROW Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 159: ROW Transdermal Drug Delivery System Market: By Type, By Value, 2018E-2023F (USD Billion)
Figure 160: ROW Transdermal Drug Delivery System Market: By Technique, By Value, 2013-2017 (USD Billion)
Figure 161: ROW Transdermal Drug Delivery System Market: By Technique, By Value, 2018-2023 (USD Billion)
Figure 162: ROW Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)
Figure 163: ROW Transdermal Drug Delivery System Market: By End User, By Value, 2018E-2023F (USD Billion)
Figure 164: Brazil Transdermal Drug Delivery System Market Size, By Value, 2013-2023 (USD Billion)
Figure 165: Brazil Population ages 65 and above, 2012-17 (% of total)
Figure 166: Brazil GDP, 2012-2017 (In USD Trillion)
Figure 167: Brazil Transdermal Drug Delivery System Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 168: Brazil Transdermal Drug Delivery System Market: By Type, By Value, 2018E-2023F (USD Billion)
Figure 169: Brazil Transdermal Drug Delivery System Market: By Technique, By Value, 2013-2017 (USD Billion)
Figure 170: Brazil Transdermal Drug Delivery System Market: By Technique, By Value, 2018-2023 (USD Billion)
Figure 171: Brazil Transdermal Drug Delivery System Market: By End User, By Value, 2013-2017 (USD Billion)
Figure 172: Brazil Transdermal Drug Delivery System Market: By End user, By Value, 2018E-2023F (USD Billion)
Figure 173: 3 M Pharmaceutical, Net Sales, 2013-2017 (In Billion USD)
Figure 174: 3 M Pharmaceutical, Net Sales, By Business Sector, 2017 (In %)
Figure 175: 3 M Pharmaceutical, Net Sales, By Geographic Region, 2017 (In %)
Figure 176: Boehringer Ingelheim, Net Sales, 2013-2017 (In Billion USD)
Figure 177: Boehringer Ingelheim, Net Sales, By Business Sector, 2017 (In %)
Figure 178: Boehringer Ingelheim, Net Sales, By Geographic Region, 2017 (In %)
Figure 179: Mylan, Sales Revenue, 2013-2017 (In USD Billion)
Figure 180: Mylan, Sales, By Business Segment, 2017 (In %)
Figure 181: Mylan, By Geographic Region, 2017 In (%)
Figure 182: Novartis, Sales Revenue, 2013-2017 (In USD Billion)
Figure 183: Novartis, Sales By Business Segment, 2017 (In %)
Figure 184: Novartis, By Geographic Region, 2017 In (%)
Figure 185: GlaxoSmithKline, Sales Revenue, 2013-2017 (In USD Billion)
Figure 186: GlaxoSmithKline, Sales, By Business Segment, 2017 (In %)
Figure 187: GlaxoSmithKline, By Geographic Region, 2017 In (%)
Figure 188: Johnson& Johnson, Sales Revenue, 2013-2017 (In USD Billion)
Figure 189: Johnson & Johnson, Sales By Business Segment, 2017 (In %)
Figure 190: Johnson & Johnson, By Geographic Region, 2017 In (%)
Figure 191: Bayer, Sales Revenue, 2013-2017 (USD Billion)
Figure 192: Bayer, Sales Revenue, 2013-2017 (USD Billion)
Figure 193: Bayer, Sales By Geographic region, FY ended March 2017 (%)

Table A: Parameters affecting selection of drugs in TDDS
Table B: Germany, Healthcare Related Statistics, 2017
Table C: Global Access to Healthcare Index, Ranking of Select Countries in Asia Pacific Region, 2017 (score out of 10)

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.